Global Cardiovascular Ultrasound Systems Market Analysis
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Mortality Worldwide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The
Takeda TSE4502NYSETAK today announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has recommended the approval of fruquintinib a selective inhibitor of vascular endothelial growth factor receptors VEGFR 1 2 and 3 for the treatment of adult patients with previously treated metastatic colorectal cancer mCRC.
− If Approved in the European Union, Fruquintinib Will Be the First Novel Targeted Therapy for Metastatic Colorectal Cancer Regardless of Biomarker Status in Over a Decade − Positive Opinion...
/PRNewswire/ -- The "Cardiac Ablation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Cardiac Ablation...